Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Clover Corporation Limited

Market Cap 146M 102M 89.51M 82.8M 77.28M 145M 9.68B 984M 383M 4.76B 385M 376M 16.54B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 146M 102M 89.51M 82.8M 77.28M 145M 9.68B 984M 383M 4.76B 385M 376M 16.54B EV / Sales 2026 *
1.63x
EV / Sales 2027 * 1.53x
Free-Float
81.15%
Yield 2026 *
2.05%
Yield 2027 * 2.73%
1 day+1.14%
1 week+2.30%
Current month-1.66%
1 month+6.59%
3 months+19.46%
6 months+11.25%
Current year+12.66%
1 week 0.85
Extreme 0.85
0.9
1 month 0.8
Extreme 0.8
1
Current year 0.7
Extreme 0.7
1.16
1 year 0.49
Extreme 0.49
1.16
3 years 0.34
Extreme 0.337
1.23
5 years 0.34
Extreme 0.337
1.88
10 years 0.34
Extreme 0.337
3.31
Manager TitleAgeSince
Chief Executive Officer - 11/11/2014
Director of Finance/CFO - 06/05/2021
Chief Operating Officer - 03/02/2011
Director TitleAgeSince
Director/Board Member - 11/11/2014
Chairman - 21/09/2017
Director/Board Member - 01/02/2017
Date Insider Type Main position Quantity % Market Cap.
11-18Buy

Chief Executive Officer

529,638 0.3171%
11-18Sell

Chief Executive Officer

255,199 0.1528%
11-06Buy

Chief Financial Officer

2,447 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
+1.14%+2.30%+63.30%-26.45% 102M
+5.18%-2.61%+35.71%+94.39% 13.35B
+1.04%-2.18%-54.55%+133.82% 4.98B
+4.68%+2.59%-6.63%-57.18% 2.54B
+6.77%+14.05% - - 1.8B
+2.83%-1.80%-19.03%-23.45% 1.28B
+1.93%+1.34%+50.87%-4.94% 1.26B
-6.10%-5.20%-63.27%-67.68% 1.07B
+7.51%+14.79%-82.70%-72.57% 1.18B
-0.63%-0.88%+2.03%+17.77% 1.06B
Average +2.43%+2.18%-8.25%-0.70% 2.86B
Weighted average by Cap. +3.71%-0.12%+2.65%+59.73%

Financials

2026 *2027 *
Net sales 89.4M 62.67M 54.76M 50.65M 47.28M 88.75M 5.92B 602M 234M 2.91B 235M 230M 10.11B 95.3M 66.8M 58.37M 53.99M 50.4M 94.61M 6.31B 642M 250M 3.1B 251M 245M 10.78B
Net income - -
Net Debt - -
Logo Clover Corporation Limited
Clover Corporation Limited focused on technology, new product development, and commercialization. The principal activities of the Company are the refining and sale of natural oils, the production of encapsulated powders and the research and product development of functional food and infant nutrition ingredients. Its microencapsulation technology enables nutritional oils, such as tuna, fish, algal and fungal oils, to be added to infant formulas, foods, and beverages. Its technologies protect those sensitive oils from oxidation, allowing them to be incorporated into a range of applications. The Company, through its subsidiary, Nu-Mega Ingredients Pty Limited (Nu-Mega), supplies refined Omega-3 oils and a range of other encapsulated ingredients for use in infant formula, nutraceuticals, pharmaceuticals, and sports nutrition markets. Nu-Mega’s Driphorm range of microencapsulated powders enables the addition of Hi-DHA tuna and/or algal oils to a broad spectrum of products.
Employees
68
Date Price Change Volume
23/06/26 A$0.8900 +1.14% 63,728
22/06/26 A$0.8800 -1.12% 12,866
19/06/26 A$0.8900 0.00% 32,163
18/06/26 A$0.8900 +2.01% 18,255
17/06/26 A$0.8725 +0.29% 13,376
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.8800AUD
Average target price
0.8700AUD
Spread / Average Target
-1.14%

Annual profits - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!